Lindbrook Capital, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$44,724
-50.4%
2,891
-49.7%
0.01%
-50.0%
Q2 2023$90,223
-26.8%
5,743
-23.2%
0.01%
-28.6%
Q1 2023$123,270
+73.9%
7,480
+64.6%
0.01%
+55.6%
Q4 2022$70,902
-17.6%
4,545
-31.7%
0.01%
-40.0%
Q3 2022$86,000
+1.2%
6,652
+10.4%
0.02%
+7.1%
Q2 2022$85,000
-18.3%
6,024
-16.8%
0.01%
-12.5%
Q1 2022$104,000
+44.4%
7,243
+37.6%
0.02%
+45.5%
Q4 2021$72,000
-21.7%
5,265
-6.7%
0.01%
-54.2%
Q3 2021$92,000
+2.2%
5,646
+5.7%
0.02%
+20.0%
Q2 2021$90,000
-29.7%
5,340
-23.9%
0.02%
-31.0%
Q1 2021$128,000
+9.4%
7,016
+9.1%
0.03%0.0%
Q4 2020$117,000
+12.5%
6,430
+10.0%
0.03%0.0%
Q3 2020$104,000
+4.0%
5,848
+4.5%
0.03%
-3.3%
Q2 2020$100,000
+53.8%
5,598
+31.3%
0.03%
+20.0%
Q1 2020$65,000
-34.3%
4,265
-15.2%
0.02%
-26.5%
Q4 2019$99,000
-1.0%
5,030
-13.4%
0.03%
-10.5%
Q3 2019$100,000
+66.7%
5,807
+69.3%
0.04%
+65.2%
Q2 2019$60,000
-61.3%
3,431
-55.0%
0.02%
-62.9%
Q1 2019$155,0007,6310.06%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders